Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 27, 2021 at 05:03 am EDT
Share
Beijing Leadman Biochemistry Co.,Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 414.31 million compared to CNY 324.79 million a year ago. Revenue was CNY 414.31 million compared to CNY 324.79 million a year ago. Net income was CNY 29.06 million compared to CNY 5 million a year ago. Basic earnings per share from continuing operations was CNY 0.0673 compared to CNY 0.012 a year ago. Diluted earnings per share from continuing operations was CNY 0.0673 compared to CNY 0.012 a year ago.
Beijing Leadman Biochemistry Co., Ltd is a China-based company principally engaged in the research, development, production and sales of in-vitro diagnostic reagents. Its diagnostic reagents include chemiluminescence diagnostic reagents and biochemical diagnostic agents, such as hepatitis B virus attributes and tumor markers. The Company also produces diagnostic instruments and biochemical raw materials. Its diagnostic instruments include automatic luminescence immunity analyzers, among others. Its products are applied in various fields, including liver diseases, kidney diseases, cardiovascular diseases, immunological diseases and diabetes, among others. The Company mainly operates businesses in domestic market.